X-Linked Hypophosphatemia clinical trials at UCSF
2 in progress, 1 open to eligible people
X-linked hypophosphatemia is a rare genetic condition causing low phosphate levels and affecting bone health. UCSF is conducting research trials to explore treatments for this disorder. One trial focuses on a new drug called KK8123 for adult patients.
First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
open to eligible people ages 18-65
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
San Francisco, California and other locations
X-linked Hypophosphatemia Disease Monitoring Program
Sorry, in progress, not accepting new patients
The objectives of this observational study are to characterize XLH disease presentation and progression and to assess long-term effectiveness and safety of burosumab.
San Francisco, California and other locations
Our lead scientists for X-Linked Hypophosphatemia research studies include Farzana Perwad, MD Anthony Portale.
Last updated: